HRPC(SH:600829)2017-04-12 16:00Financial Performance - Net profit attributable to shareholders increased by 3.51% to CNY 66,055,291.39 year-on-year[7] - Operating revenue decreased by 9.81% to CNY 2,077,798,866.20 compared to the same period last year[7] - The weighted average return on equity decreased by 0.09 percentage points to 4.30%[7] - Total operating revenue for Q1 2017 was 2,020,706,561.39 RMB, an increase from 1,921,597,227.12 RMB in the same period last year, representing a growth of approximately 5.5%[33] - Net profit for Q1 2017 reached 66,055,291.39 RMB, compared to 63,817,318.13 RMB in Q1 2016, marking an increase of about 3.9%[27] - Operating profit for Q1 2017 was 87,840,072.31 RMB, slightly up from 84,837,249.07 RMB in the previous year, indicating a growth of approximately 3.5%[26] - The total profit for Q1 2017 was 89,762,878.71 RMB, up from 86,091,844.36 RMB in the same quarter last year, representing an increase of about 3.1%[26] Assets and Liabilities - Total assets decreased by 3.82% to CNY 4,626,115,867.08 compared to the end of the previous year[7] - Total assets decreased from CNY 4,810,079,828.61 at the beginning of the year to CNY 4,626,115,867.08 by the end of the period, a decline of approximately 3.81%[19] - Current assets decreased from CNY 4,261,233,290.88 to CNY 4,085,761,343.00, representing a decrease of about 4.14%[19] - Total liabilities increased from CNY 3,162,303,327.40 to CNY 3,202,228,372.98, an increase of approximately 1.26%[20] - Total equity decreased from CNY 1,647,776,501.21 to CNY 1,423,887,494.10, a decrease of about 13.6%[20] Cash Flow - Cash flow from operating activities increased significantly by 801.32% to CNY 87,299,929.22[7] - The cash flow from operating activities was 2,020,706,561.39 RMB in Q1 2017, compared to 1,921,597,227.12 RMB in the same period last year, indicating an increase of about 5.2%[33] - The net cash flow from operating activities for Q1 2017 was ¥87,299,929.22, a significant increase from ¥9,685,749.82 in the previous year, representing a growth of approximately 800%[34] - Total cash inflow from operating activities was ¥2,022,309,954.63, compared to ¥1,924,006,516.05 in the same period last year, indicating a year-over-year increase of about 5.1%[34] - Cash outflow from operating activities totaled ¥1,935,010,025.41, slightly up from ¥1,914,320,766.23, resulting in a marginal increase of 1.1%[34] - The net cash flow from investing activities was -¥1,791,886.91, an improvement from -¥3,973,288.97 in the previous year, showing a reduction in cash outflow by approximately 55%[34] - Cash inflow from financing activities was ¥14,000,000.00, with a net cash flow of ¥12,758,075.00 after accounting for cash outflows, compared to a net outflow of -¥1,556,152.50 in the previous year[35] Shareholder Information - The number of shareholders reached 17,309 at the end of the reporting period[11] - The largest shareholder, Harbin Pharmaceutical Group Co., Ltd., holds 74.82% of the shares[11] Expenses - Financial expenses increased by 155.53% to CNY 1,724,175.46 due to increased discount interest[13] - The company reported a net asset impairment loss of CNY -7,526,093.86, a decrease of 154.56% compared to the previous year[13] - The income tax expense for Q1 2017 was 23,707,587.32 RMB, compared to 22,274,526.23 RMB in Q1 2016, which is an increase of approximately 6.4%[26] - The company reported a decrease in sales expenses to 63,136,031.94 RMB in Q1 2017 from 50,435,292.44 RMB in Q1 2016, indicating a rise of about 25.2%[26] - Management expenses increased to 70,327,292.92 RMB in Q1 2017 from 68,417,248.48 RMB in Q1 2016, reflecting a growth of approximately 2.8%[26] Inventory and Receivables - Accounts receivable decreased from CNY 2,707,111,900.15 to CNY 2,537,654,493.47, a decline of about 6.27%[18] - Inventory decreased from CNY 761,962,079.19 to CNY 642,854,302.36, a reduction of approximately 15.6%[18]